{
    "en_vn": {
        "data": {
            "content": null,
            "word": "biotech",
            "pronounce": ""
        }
    },
    "en_en": {
        "data": {
            "content": "<div class=\"dict--title\">Anh - Anh</div><div class=\"dict--content\"><k>biotech</k><blockquote>\u25a0 <cclass>noun short for <kref>biotechnology</kref>. </cclass></blockquote></div>",
            "word": "biotech",
            "pronounce": ""
        }
    },
    "synonyms": {
        "data": {
            "content": null,
            "word": "biotech",
            "pronounce": ""
        }
    },
    "grammar": {
        "data": {
            "content": null,
            "word": "biotech",
            "pronounce": ""
        }
    },
    "specialist": {
        "data": {
            "content": null,
            "word": "biotech",
            "pronounce": ""
        }
    },
    "sentences": [
        {
            "en": "I will be a <em>biotech</em> engineer.",
            "vi": "T\u00f4i s\u1ebd tr\u1edf th\u00e0nh m\u1ed9t k\u1ef9 s\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."
        },
        {
            "en": "Geron, a <em>biotech</em> company based in \"silicon valley\" south of San Francisco, has spent US$170m on developing a stem cell treatment for spinal cord injury.",
            "vi": "Geron, m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 tr\u1ee5 s\u1edf t\u1ea1i \"Thung l\u0169ng Silicon\"\u1edf ph\u00eda nam San Francisco \u0111\u00e3 chi 170 tri\u1ec7u \u0111\u00f4 - la M\u1ef9 \u0111\u1ec3 ph\u00e1t tri\u1ec3n \u0111i\u1ec1u tr\u1ecb t\u1ed5n th\u01b0\u01a1ng c\u1ed9t s\u1ed1ng b\u1eb1ng"
        },
        {
            "en": "Geron, a <em>biotech</em> company based in \"silicon valley\" south of San Francisco, has spent US$170m on developing a stem cell treatment for spinal cord injury.",
            "vi": "Geron, m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 tr\u1ee5 s\u1edf t\u1ea1i \" Thung l\u0169ng Silicon \" \u1edf ph\u00eda nam San Francisco \u0111\u00e3 chi 170 tri\u1ec7u \u0111\u00f4-la M\u1ef9 \u0111\u1ec3 ph\u00e1t tri\u1ec3n \u0111i\u1ec1u tr\u1ecb t\u1ed5n th\u01b0\u01a1ng c\u1ed9t s\u1ed1ng b\u1eb1ng t\u1ebf b\u00e0o g\u1ed1c."
        },
        {
            "en": "Faber, the editor and publisher of the Gloom, Boom & Doom Report, has recently called for growth stocks to decline. And he says the pain in the Internet and <em>biotech</em> sectors is just getting started.",
            "vi": "Faber, ng\u01b0\u1eddi bi\u00ean t\u1eadp v\u00e0 xu\u1ea5t b\u1ea3n \u1ea5n ph\u1ea9m Gloom Boom & Doom Report, g\u1ea7n \u0111\u00e2y d\u1ef1 b\u00e1o c\u00e1c c\u1ed5 phi\u1ebfu t\u0103ng tr\u01b0\u1edfng s\u1ebd s\u1ee5t gi\u1ea3m. V\u00e0 \u00f4ng n\u00f3i n\u1ed7i th\u1ed1ng kh\u1ed5 c\u1ee7a c\u00e1c c\u1ed5 phi\u1ebfu trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u00e0 Internet ch\u1ec9 m\u1edbi b\u1eaft \u0111\u1ea7u m\u00e0 th\u00f4i."
        },
        {
            "en": "Business boils down to personal interactions, and exposure to new ideas challenges you and expands your understanding of viewpoints, says Joan Fallon, CEO of the <em>biotech</em> company\u00a0Curemark, who reads a book a week. \u201cReading forces me to stop thinking about my day-to-day life for long enough that I often find a new perspective or a new way of thinking about something,\u201d she says.",
            "vi": "Joan Fallon, Gi\u00e1m \u0111\u1ed1c \u0111i\u1ec1u h\u00e0nh c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc Curemark, ng\u01b0\u1eddi m\u1ed7i tu\u1ea7n \u0111\u1ec1u \u0111\u1ecdc m\u1ed9t quy\u1ec3n s\u00e1ch, n\u00f3i: \"Vi\u1ec7c kinh doanh th\u1ef1c ch\u1ea5t l\u00e0 nh\u1eefng t\u01b0\u01a1ng t\u00e1c c\u00e1 nh\u00e2n v\u00e0 vi\u1ec7c ti\u1ebfp x\u00fac v\u1edbi c\u00e1c \u00fd t\u01b0\u1edfng m\u1edbi s\u1ebd t\u1ea1o th\u00e1ch th\u1ee9c \u0111\u1ed3ng th\u1eddi m\u1edf r\u1ed9ng t\u1ea7m hi\u1ec3u bi\u1ebft v\u1ec1 quan \u0111i\u1ec3m c\u1ee7a b\u1ea1n. \"\u0110\u1ecdc s\u00e1ch bu\u1ed9c t\u00f4i ph\u1ea3i ng\u1eebng suy ngh\u0129 v\u1ec1 cu\u1ed9c s\u1ed1ng h\u1eb1ng ng\u00e0y, th\u1eddi gian \u0111\u00f3 th\u01b0\u1eddng \u0111\u1ee7 \u0111\u1ec3 t\u00f4i t\u00ecm ra m\u1ed9t vi\u1ec5n c\u1ea3nh m\u1edbi ho\u1eb7c m\u1ed9t c\u00e1ch suy ngh\u0129 m\u1edbi v\u1ec1 \u0111i\u1ec1u g\u00ec \u0111\u00f3\", b\u00e0 n\u00f3i."
        },
        {
            "en": "First trial of embryonic stem cells in humans         US doctors have begun the first official trial of using human embryonic stem cells in patients after getting the green light from regulators. The Food and Drug Administration has given a license to Geron to use the controversial cells to treat people with spinal injuries. The cells have the potential to become many of the different cell types found in the body, including nerve cells. The trials at a hospital in Atlanta will check if the treatment is safe. Pivotal research  Geron, a <em>biotech</em> company based in \"silicon valley\" south of San Francisco, has spent $170m on developing a stem cell treatment for spinal cord injury.  The research will use cells coaxed to become nerve cells which are injected into the spinal cord.  In animal trials of the treatment, paralysed rats regained some movement.  But it is not yet known if it will offer any benefit to people with spinal cord injuries. Every year around 12,000 people in the US sustain spinal cord injuries. The most common causes are automobile accidents, falls, gunshot wounds and sports injuries. In the trial, patients who have sustained such an injury within the last 14 days will be given the experimental stem cell treatment. Geron president Dr Thomas Okarma said: \"When we started working with human embryonic stem cells in 1999, many predicted that it would be a number of decades before a cell therapy would be approved for human clinical trials.  \"This accomplishment results from extensive research and development and a succession of inventive steps.\" But it will take some time to get the results. And there are many years of rigorous testing ahead before it can be known if the therapy is safe and effective. Professor Sir Ian Wilmut, director of the Medical Research Council Centre for Regenerative Medicine at the University of Edinburgh, said: \"This is very exciting news, however, it is very important to appreciate that the objective of trials at this stage is to confirm first of all that no harm is done to patients, rather than to look for benefits.  \"Once that has been confirmed then the focus moves on to development and assessment of the new treatment.\" Ben Sykes, executive director of the UK National Stem Cell Network, said: \"This is indeed a significant milestone in our journey towards the promise of stem cell-based medicines.  \"The global stem cell and regenerative medicine community will be awaiting the results of this safety trial with much anticipation.\" Professor Chris Mason, an expert in regenerative medicine at University College London, said UK researchers hope to follow suit and begin trials next year with a stem cell treatment for age-related macular degeneration - a leading cause of blindness.",
            "vi": "Cu\u1ed9c th\u1eed nghi\u1ec7m \u0111\u1ea7u ti\u00ean v\u1ec1 t\u1ebf b\u00e0o g\u1ed1c \u1edf ng\u01b0\u1eddi trong th\u1eddi k\u1ef3 \u0111\u1ea7u ph\u00e1t tri\u1ec3n       C\u00e1c b\u00e1c si\u0303 \u1edf Hoa Ky\u0300 \u0111a\u0303 b\u1eaft \u0111\u1ea7u cu\u1ed9c th\u01b0\u0309 nghi\u1ec7m ch\u00ednh th\u1ee9c \u0111\u1ea7u ti\u00ean s\u01b0\u0309 d\u1ee5ng t\u00ea\u0301 b\u00e0o g\u1ed1c \u1edf ng\u01b0\u1eddi trong th\u1eddi ky\u0300 \u0111\u1ea7u ph\u00e1t tri\u1ec3n \u1edf b\u1ec7nh nh\u00e2n sau khi nh\u1eadn \u0111\u01b0\u1ee3c t\u00edn hi\u1ec7u cho ph\u00e9p th\u1ef1c hi\u1ec7n t\u01b0\u0300 nh\u1eefng ng\u01b0\u1eddi \u0111i\u1ec1u h\u00e0nh. C\u01a1 quan Qu\u1ea3n ly\u0301 Th\u1ef1c ph\u1ea9m va\u0300 D\u01b0\u1ee3c ph\u1ea9m Hoa Ky\u0300 \u00a0\u0111a\u0303 c\u1ea5p gi\u1ea5y ph\u00e9p cho Geron s\u01b0\u0309 d\u1ee5ng lo\u1ea1i t\u00ea\u0301 b\u00e0o g\u00e2y tranh c\u00e3i n\u00e0y \u0111\u00ea\u0309 ch\u1eefa tr\u1ecb cho b\u1ec7nh nh\u00e2n b\u1ecb t\u1ed5n th\u01b0\u01a1ng c\u1ed9t s\u1ed1ng. C\u00e1c t\u00ea\u0301 b\u00e0o n\u00e0y c\u00f3 kha\u0309 n\u0103ng tr\u01a1\u0309 th\u00e0nh nhi\u1ec1u lo\u1ea1i t\u00ea\u0301 b\u00e0o kh\u00e1c nhau \u0111\u01b0\u1ee3c t\u00ecm th\u1ea5y trong c\u01a1 th\u00ea\u0309 k\u00ea\u0309 c\u1ea3 t\u00ea\u0301 b\u00e0o th\u1ea7n kinh. Cu\u1ed9c th\u01b0\u0309 nghi\u1ec7m \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n t\u1ea1i m\u1ed9t b\u1ec7nh vi\u1ec7n \u1edf Atlanta s\u1ebd ki\u1ec3m tra li\u1ec7u vi\u1ec7c \u0111i\u1ec1u tr\u1ecb n\u00e0y c\u00f3 an to\u00e0n hay kh\u00f4ng. Nghi\u00ean c\u1ee9u c\u1ef1c ky\u0300 quan tr\u1ecdng Geron, m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u00ea\u0323 sinh h\u1ecdc c\u00f3 tr\u1ee5 s\u01a1\u0309 t\u1ea1i \" Thung lu\u0303ng Silicon \" \u1edf ph\u00eda nam San Francisco \u0111a\u0303 chi 170 tri\u1ec7u \u0111\u00f4-la M\u1ef9 \u0111\u00ea\u0309 ph\u00e1t tri\u1ec3n \u0111i\u1ec1u tr\u1ecb t\u1ed5n th\u01b0\u01a1ng c\u1ed9t s\u1ed1ng b\u1eb1ng t\u00ea\u0301 b\u00e0o g\u1ed1c. Nghi\u00ean c\u1ee9u n\u00e0y s\u1ebd s\u01b0\u0309 d\u1ee5ng c\u00e1c t\u00ea\u0301 b\u00e0o \u0111a\u0303 l\u1ea5y \u0111\u01b0\u1ee3c tr\u01a1\u0309 th\u00e0nh t\u00ea\u0301 b\u00e0o th\u1ea7n kinh \u0111\u00ea\u0309 ti\u00eam v\u00e0o tuy\u0309 s\u1ed1ng. Trong th\u01b0\u0309 nghi\u1ec7m \u0111i\u1ec1u tr\u1ecb \u1edf \u0111\u1ed9ng v\u1eadt, chu\u1ed9t b\u1ecb t\u00ea li\u1ec7t \u0111a\u0303 l\u1ea5y l\u1ea1i \u0111\u01b0\u1ee3c v\u00e0i c\u01b0\u0309 \u0111\u1ed9ng. Nh\u01b0ng th\u01b0\u0309 nghi\u1ec7m n\u00e0y c\u00f2n ch\u01b0a \u0111\u01b0\u1ee3c bi\u1ebft \u0111\u1ebfn n\u1ebfu n\u00f3 \u0111\u01b0a ra b\u1ea5t ky\u0300 s\u00f4\u0301 ti\u1ec1n theo y\u00eau c\u1ea7u n\u00e0o \u0111\u1ed1i v\u1edbi ng\u01b0\u1eddi b\u1ecb t\u1ed5n th\u01b0\u01a1ng c\u1ed9t s\u1ed1ng. H\u00e0ng n\u0103m c\u00f3 kho\u1ea3ng 12000 ng\u01b0\u1eddi \u1edf Hoa Ky\u0300 b\u1ecb t\u1ed5n th\u01b0\u01a1ng c\u1ed9t s\u1ed1ng. Nguy\u00ean nh\u00e2n ph\u00f4\u0309 bi\u1ebfn nh\u1ea5t l\u00e0 do tai n\u1ea1n xe c\u00f4\u0323, nga\u0303, v\u1ebft th\u01b0\u01a1ng do \u0111\u1ea1n b\u1eafn ho\u1eb7c ch\u1ea5n th\u01b0\u01a1ng do ch\u01a1i th\u00ea\u0309 thao. Trong th\u01b0\u0309 nghi\u1ec7m n\u00e0y, b\u1ec7nh nh\u00e2n ph\u1ea3i ch\u1ecbu t\u1ed5n th\u01b0\u01a1ng k\u00e9o d\u00e0i trong v\u00f2ng 14 ng\u00e0y thi\u0300 s\u1ebd \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb thi\u0301 nghi\u1ec7m b\u1eb1ng t\u00ea\u0301 b\u00e0o g\u1ed1c. Ti\u1ebfn si\u0303 Thomas Okarma, ch\u1ee7 t\u1ecbch c\u1ee7a Geron n\u00f3i r\u1eb1ng: \u201cKhi chu\u0301ng t\u00f4i b\u1eaft \u0111\u1ea7u c\u00f4ng vi\u1ec7c v\u1edbi t\u00ea\u0301 b\u00e0o g\u1ed1c trong th\u1eddi ky\u0300 \u0111\u1ea7u ph\u00e1t tri\u1ec3n \u1edf ng\u01b0\u1eddi v\u00e0o n\u0103m 1999, c\u00f3 nhi\u1ec1u d\u01b0\u0323 \u0111o\u00e1n cho r\u1eb1ng n\u00f3 s\u1ebd l\u00e0 m\u1ed9t th\u00e0nh t\u1ef1u \u0111\u00e1ng k\u00ea\u0309 c\u1ee7a nhi\u1ec1u th\u1eadp ky\u0309 tr\u01b0\u1edbc khi tr\u1ecb li\u1ec7u t\u00ea\u0301 b\u00e0o \u0111\u01b0\u1ee3c ch\u1ea5p nh\u1eadn \u0111\u00ea\u0309 th\u01b0\u0309 nghi\u1ec7m \u0111i\u1ec1u tr\u1ecb cho ng\u01b0\u1eddi.\u201d \u201c Tha\u0300nh c\u00f4ng n\u00e0y c\u00f3 \u0111\u01b0\u1ee3c t\u01b0\u0300 vi\u1ec7c nghi\u00ean c\u1ee9u, ph\u00e1t tri\u1ec3n tr\u00ean ph\u1ea1m vi r\u1ed9ng va\u0300 m\u1ed9t chu\u1ed1i c\u00e1c b\u01b0\u1edbc \u0111\u1ea7y s\u00e1ng t\u1ea1o.\u201d Nh\u01b0ng s\u1ebd m\u1ea5t m\u1ed9t kho\u1ea3ng th\u1eddi gian \u0111\u00ea\u0309 c\u00f3 \u0111\u01b0\u1ee3c k\u1ebft qu\u1ea3 n\u00e0y. Va\u0300 ph\u1ea3i tr\u1ea3i qua nhi\u1ec1u n\u0103m th\u01b0\u0309 nghi\u1ec7m nghi\u00eam ng\u1eb7t tr\u01b0\u1edbc tr\u01b0\u1edbc khi n\u00f3 \u0111\u01b0\u1ee3c bi\u1ebft \u0111\u1ebfn n\u1ebfu tr\u1ecb li\u1ec7u n\u00e0y an to\u00e0n va\u0300 hi\u1ec7u qu\u1ea3. Gi\u00e1o s\u01b0 Sir Ian Wilmut, gi\u00e1m \u0111\u1ed1c H\u1ed9i \u0111\u1ed3ng Nghi\u00ean c\u1ee9u Y khoa thu\u1ed9c Trung t\u00e2m nghi\u00ean c\u1ee9u thu\u1ed1c t\u00e1i ph\u1ee5c h\u1ed3i t\u1ea1i \u0111\u1ea1i h\u1ecdc Edinburgh cho bi\u1ebft: \u201c \u0110\u00e2y l\u00e0 tin r\u1ea5t thu\u0301 v\u1ecb, tuy nhi\u00ean \u0111i\u1ec1u quan tr\u1ecdng l\u00e0 ph\u1ea3i hi\u1ec3u ro\u0303 gia\u0301 tr\u1ecb m\u1ee5c ti\u00eau c\u1ee7a th\u01b0\u0309 nghi\u1ec7m \u1edf giai \u0111o\u1ea1n n\u00e0y va\u0300 ph\u1ea3i x\u00e1c nh\u1eadn \u0111i\u1ec1u \u0111\u1ea7u ti\u00ean ph\u1ea3i l\u00e0m l\u00e0 kh\u00f4ng g\u00e2y h\u1ea1i cho b\u1ec7nh nh\u00e2n ch\u01b0\u0301 kh\u00f4ng ph\u1ea3i l\u00e0 l\u1ee3i nhu\u1eadn n\u00f3 mang l\u1ea1i. \u201cNgay khi \u0111i\u1ec1u \u0111o\u0301 \u0111\u01b0\u1ee3c x\u00e1c nh\u1eadn thi\u0300 c\u1ea7n ph\u1ea3i t\u1eadp trung ti\u1ebfp t\u1ee5c ph\u00e1t tri\u1ec3n va\u0300 \u0111\u00e1nh gia\u0301 vi\u1ec7c \u0111i\u1ec1u tr\u1ecb m\u1edbi n\u00e0y.\u201d Ben Sykes, , gi\u00e1m \u0111\u1ed1c \u0111i\u1ec1u h\u00e0nh c\u1ee7a H\u00ea\u0323 th\u1ed1ng T\u00ea\u0301 b\u00e0o G\u1ed1c Qu\u1ed1c gia thu\u1ed9c V\u01b0\u01a1ng qu\u1ed1c Anh cho hay: \u201c \u0110\u00e2y qu\u1ea3 l\u00e0 m\u1ed9t s\u01b0\u0323 ki\u1ec7n quan tr\u1ecdng c\u00f3 \u00fd ngh\u0129a trong cu\u1ed9c h\u00e0nh tr\u00ecnh h\u1ee9a h\u1eb9n v\u00ea\u0300 vi\u1ec7c \u0111i\u1ec1u tr\u1ecb b\u1eb1ng t\u00ea\u0301 b\u00e0o g\u1ed1c.\u201d \u201cH\u1ed9i nghi\u00ean c\u1ee9u thu\u1ed1c t\u00e1i ph\u1ee5c h\u1ed3i va\u0300 t\u00ea\u0301 b\u00e0o g\u1ed1c to\u00e0n c\u1ea7u \u0111ang ch\u01a1\u0300 \u0111\u1ee3i k\u1ebft qu\u1ea3 th\u01b0\u0309 nghi\u1ec7m an to\u00e0n cu\u0300ng v\u1edbi vi\u1ec7c \u0111\u00ea\u0300 ph\u00f2ng l\u1edbn.\u201d Gi\u00e1o s\u01b0 Chris Mason, m\u1ed9t chuy\u00ean gia trong l\u0129nh v\u01b0\u0323 nghi\u00ean c\u1ee9u thu\u1ed1c t\u00e1i ph\u1ee5c h\u1ed3i t\u1ea1i tr\u01b0\u1eddng \u0110\u1ea1i h\u1ecdc College London n\u00f3i r\u1eb1ng c\u00e1c nha\u0300 nghi\u00ean c\u1ee9u V\u01b0\u01a1ng qu\u1ed1c Anh hy v\u1ecdng s\u1ebd ti\u1ebfp b\u01b0\u1edbc ph\u01b0\u01a1ng ph\u00e1p n\u00e0y va\u0300 s\u1ebd b\u1eaft \u0111\u1ea7u cu\u1ed9c th\u01b0\u0309 nghi\u1ec7m v\u00e0o n\u0103m t\u1edbi b\u1eb1ng \u0111i\u1ec1u tr\u1ecb t\u00ea\u0301 b\u00e0o g\u1ed1c \u0111\u1ed1i v\u1edbi suy tho\u00e1i v\u00f5ng m\u1ea1c do tu\u1ed5i gia\u0300- m\u1ed9t nguy\u00ean nh\u00e2n h\u00e0ng \u0111\u1ea7u v\u00ea\u0300 b\u1ec7nh \u0111ui mu\u0300."
        }
    ],
    "suggestions": []
}